Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125039532 | 12503953 | 2 | F | 20160616 | 20160713 | 20160628 | 20160720 | EXP | US-ASTELLAS-2016US024191 | ASTELLAS | 48.69 | YR | M | Y | 0.00000 | 20160720 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125039532 | 12503953 | 1 | PS | VESICARE | SOLIFENACIN SUCCINATE | 1 | Unknown | U | L1500129 | 21518 | 10 | MG | TABLET | QD | |||||
| 125039532 | 12503953 | 2 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | 750 | MG | FORMULATION UNKNOWN | |||||||
| 125039532 | 12503953 | 3 | C | CLOZAPINE. | CLOZAPINE | 1 | Unknown | U | 0 | 150 | MG | FORMULATION UNKNOWN | |||||||
| 125039532 | 12503953 | 4 | C | LITHIUM. | LITHIUM | 1 | Oral | U | 0 | 600 | MG | FORMULATION UNKNOWN | BID | ||||||
| 125039532 | 12503953 | 5 | C | DOCUSATE | DOCUSATE | 1 | Unknown | U | 0 | 100 | MG | FORMULATION UNKNOWN | |||||||
| 125039532 | 12503953 | 6 | C | SUPER BETA PROSTATE | DIETARY SUPPLEMENT | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 125039532 | 12503953 | 7 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | U | 0 | 81 | MG | FORMULATION UNKNOWN | QD | ||||||
| 125039532 | 12503953 | 8 | C | DIOVAN | VALSARTAN | 1 | Oral | U | 0 | 80 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125039532 | 12503953 | 1 | Pollakiuria |
| 125039532 | 12503953 | 2 | Product used for unknown indication |
| 125039532 | 12503953 | 3 | Product used for unknown indication |
| 125039532 | 12503953 | 4 | Product used for unknown indication |
| 125039532 | 12503953 | 5 | Product used for unknown indication |
| 125039532 | 12503953 | 6 | Product used for unknown indication |
| 125039532 | 12503953 | 7 | Product used for unknown indication |
| 125039532 | 12503953 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125039532 | 12503953 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125039532 | 12503953 | Constipation | |
| 125039532 | 12503953 | Faecal volume increased | |
| 125039532 | 12503953 | Haematochezia | |
| 125039532 | 12503953 | Intestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125039532 | 12503953 | 1 | 201604 | 201606 | 0 |